Johns Hopkins Investigators Develop Novel Treatment for T-cell Leukemias and Lymphomas | Naviance

Johns Hopkins Investigators Develop Novel Treatment for T-cell Leukemias and Lymphomas

Johns Hopkins Investigators Develop Novel Treatment for T-cell Leukemias and Lymphomas

Investigators at the Johns Hopkins Kimmel Cancer Center have developed a novel treatment that kills human T-cell tumors in mice.

READ HERE

Recent Posts

Variations In Telomere Lengthening Genes May Predispose Some People to Papillary Thyroid Cancer Proximity to a Cancer Center Contributes to Cancer Stage at Diagnosis Novel therapy reprograms immune cells Video: Face and jaw reconstruction after cancer surgery Combination Urothelial Cancer Treatment Nearly Doubles Patient Survival in International Trial Age-Related Changes in Skin May Contribute to Melanoma Metastases RNA-Based Therapy Shows Promise Against Aggressive Childhood Brain Tumors in Mice Johns Hopkins Researchers Develop Test to ID Aggressive Ovarian Cancers Early Personalized Vaccine for Liver Cancer Shows Promise in Clinical Trial